EUVIMEDEUVIMED entdecken
Multizentrische Studie

Pushing the Boundaries of Stereotactic Body Radiation Therapy in Irradiated Territories for Nodal Oligorecurrent Prostate Cancer: Outcomes of the CYGNUS Multicentric Retrospective Study

Ewen Anger, Stephane Supiot, Quentin Josset, David Pasquier, Loïg Vaugier, François-Georges Riet, Yoann Pointreau, Amandine Ruffier, Geneviève Loos, Mario Terlizzi, Pierre Blanchard, Etienne Martin und 12 weitere

International Journal of Radiation Oncology*Biology*Physics · 2026-09 · 126 (1) · 182-192

DOI: 10.1016/j.ijrobp.2026.03.020 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift International Journal of Radiation Oncology*Biology*Physics, 2026-09. Verfasst von Ewen Anger und 23 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiotherapy, Centre Eugène Marquis, Rennes, France. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Radiosurgery, Neoplasm Recurrence, Local, Salvage Therapy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE the CYGNUS study aims to assess both toxicity and efficacy of stereotactic body radiotherapy (SBRT) performed as salvage approach for pelvic nodal metachronous oligorecurrent (PNMOR) hormone-sensitive prostate cancer (PCa), in previously irradiated territory. METHODS AND MATERIALS Inclusion criteria were histologically history of proven PCa, locally treated with a radical intent and a biochemical relapse as defined by the European Association of Urology guidelines. All patients had a radiological suspicion of PNMOR, defined as a recurrence occurring in pelvic nodal areas with up to 5 suspect lymph nodes. Reirradiation was defined according to the ESTRO-EORTC consensus on re-irradiation as an irradiation with a geometrical overlap with a previous course of RT. RESULTS A total of 155 re-irradiation among 150 patients relapsing on 192 nodal sites were retrospectively included, from 13 French centers. The majority of patients (80.7%) received radical prostatectomy as primary treatment. After a median follow-up of 30.5 months, late grade 2 and grade 3 GI and GU toxicity occurred in 1.9%, 0% and 7.1% and 2.6% of the cases, respectively. The 2-year radiological progression-free survival (rPFS) reached respectively 44.6% (95% CI: 36.2% - 55%).. The 2-year androgen deprivation therapy-free survival (ADT-FS) reached 52.6% (95% CI: 42% - 65.9%). Previous ADT prescription was predictive in multivariable analysis of both rPFS (HR:2.02, 95%CI: 1.25-3.26, p=0.004) and ADT-FS (HR:2.49, 95%CI: 1.28-4.72, p=0.006). A PSA doubling time

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsRadiosurgeryNeoplasm Recurrence, LocalSalvage TherapyMaleRetrospective StudiesHumansRe-IrradiationAgedLymphatic MetastasisTreatment OutcomeAged, 80 and overProstate-Specific AntigenProstatectomyFrance

Substanzen

Prostate-Specific Antigen

Autor:innen und Institutionen

  • Department of Radiotherapy, Centre Eugène Marquis, Rennes, France.
  • Department of Radiation Oncology, Institut de Cancérologie de l'Ouest, Nantes, France.
  • Department of Radiation Oncology, Institut de Cancérologie de l'Ouest, Angers, France.
  • Academic Radiation Oncology Department, Centre Oscar Lambret, Lille, France.
  • Department of Radiation Oncology, Institut de Cancérologie Régional Bretillien, Saint Grégoire, France.
  • Department of Radiation Oncology, Centre Jean Bernard, Le Mans, France.

Zitieren

APA

Anger, E., Supiot, S., Josset, Q., Pasquier, D., Vaugier, L., Riet, F. G., Pointreau, Y., Ruffier, A., Loos, G., Terlizzi, M., Blanchard, P., Martin, E., Sargos, P., Guerni, M., Schick, U., Bera, G., Roman, J., Latorzeff, I., Créhange, G., …, & Le Guévelou, J. (2026). Pushing the Boundaries of Stereotactic Body Radiation Therapy in Irradiated Territories for Nodal Oligorecurrent Prostate Cancer: Outcomes of the CYGNUS Multicentric Retrospective Study. International Journal of Radiation Oncology*Biology*Physics, 126(1), 182-192. https://doi.org/10.1016/j.ijrobp.2026.03.020

Vancouver

Anger E, Supiot S, Josset Q, Pasquier D, Vaugier L, Riet FG, et al. Pushing the Boundaries of Stereotactic Body Radiation Therapy in Irradiated Territories for Nodal Oligorecurrent Prostate Cancer: Outcomes of the CYGNUS Multicentric Retrospective Study. International Journal of Radiation Oncology*Biology*Physics. 2026;126(1):182-192. doi:10.1016/j.ijrobp.2026.03.020

BibTeX
@article{Anger2026,
  author = {Anger, Ewen and Supiot, Stephane and Josset, Quentin and Pasquier, David and Vaugier, Loïg and Riet, François-Georges and Pointreau, Yoann and Ruffier, Amandine and Loos, Geneviève and Terlizzi, Mario and Blanchard, Pierre and Martin, Etienne and Sargos, Paul and Guerni, Marie and Schick, Ulrike and Bera, Guillaume and Roman, Julien and Latorzeff, Igor and Créhange, Gilles and Castelli, Joël and Barateau, Anais and De Crevoisier, Renaud and Nicosia, Luca and Le Guévelou, Jennifer},
  title = {Pushing the Boundaries of Stereotactic Body Radiation Therapy in Irradiated Territories for Nodal Oligorecurrent Prostate Cancer: Outcomes of the CYGNUS Multicentric Retrospective Study},
  journal = {International Journal of Radiation Oncology*Biology*Physics},
  year = {2026},
  volume = {126},
  number = {1},
  pages = {182--192},
  doi = {10.1016/j.ijrobp.2026.03.020}
}
Kostenlos starten →